Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population Journal Article


Authors: Qi, S.; Yahalom, J.; Hsu, M.; Chelius, M.; Lunning, M.; Moskowitz, A.; Horwitz, S.
Article Title: Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
Abstract: Extra-nodal NK/T-cell lymphoma, nasal type (EN-NK/TCL-NT), is rare in the Western world. We launched the current single-institutional retrospective study with Institutional Review Board approval to better understand the disease. 43 EN-NK/TCL-NT patients treated from 1996 to 2014 were analyzed, including 10 (23%) Asians and 33 (76%) non-Asians. 19/26 (73%) early-stage patients received short-course chemotherapy followed by radiotherapy. 14/17 (82%) advanced-stage patients received primary chemotherapy. Complete response rate was significantly higher in the modified-SMILE group than the accelerated-CHOP group (80% vs. 30%, p = 0.015). The 2-year overall survival (OS) and progression-free survival (PFS) were 60% and 40%, respectively. Early-stage disease had significantly higher 2-year OS (87% vs. 21%) and PFS (56% vs.18%) than advanced-stage (p < 0.001). Ethnicity had no prognostic difference. EN-NK/TCL-NT in non-Asians shared similar disease characteristics and treatment outcomes with Asians. Most early-stage patients have achieved durable remissions. Management of advanced-stage disease remains challenging, with frequent progression and high mortality. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: radiotherapy; drug therapy; ethnology; smile; extranodal nk-t-cell lymphomas
Journal Title: Leukemia and Lymphoma
Volume: 57
Issue: 11
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2016-05-17
Start Page: 2575
End Page: 2583
Language: English
DOI: 10.1080/10428194.2016.1180689
PROVIDER: scopus
PUBMED: 27183991
PMCID: PMC5592793
DOI/URL:
Notes: Article -- Export Date: 1 November 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Meier Hsu
    169 Hsu
  2. Joachim Yahalom
    625 Yahalom
  3. Matthew Alexander Lunning
    31 Lunning
  4. Steven M Horwitz
    645 Horwitz
  5. Alison Moskowitz
    339 Moskowitz
  6. Shunan Qi
    14 Qi
  7. Monica Rose Chelius
    16 Chelius